Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. Resources
  3. Guidance on Code Application
  4. Pre-planned extension studies
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

Pre-planned extension studies

Scheduled Pinned Locked Moved Guidance on Code Application
4 Posts 2 Posters 1.1k Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • K Offline
    K Offline
    KEOCA
    wrote on last edited by
    #1

    Re: Guidance Regarding Duration of Clinical Trials Used as Reference Support in Advertising

    Can you elaborate on as to what demonstrates that an extension study was pre-planned? If there was a registered protocol and after primary trial completion, participants were invited to register for the long-term extension, does that qualify as pre-planned? If yes, would publication of a post hoc interim analysis of that pre-planned extension study qualify under the guidance, or would only the final analysis qualify as reference support?

    Jennifer CarrollJ 1 Reply Last reply
    0
    • K KEOCA

      Re: Guidance Regarding Duration of Clinical Trials Used as Reference Support in Advertising

      Can you elaborate on as to what demonstrates that an extension study was pre-planned? If there was a registered protocol and after primary trial completion, participants were invited to register for the long-term extension, does that qualify as pre-planned? If yes, would publication of a post hoc interim analysis of that pre-planned extension study qualify under the guidance, or would only the final analysis qualify as reference support?

      Jennifer CarrollJ Offline
      Jennifer CarrollJ Offline
      Jennifer Carroll
      wrote on last edited by
      #2

      Great question @keoca

      “Pre-planned” means “planned at least prior to the initiation of the extension”. Post hoc, ad hoc, and exploratory analyses are not acceptable. In other words, any of the following would support “pre-planned” with regards to the extension:

      a) if the parent published study’s methodology section includes the a priori plan for the extension

      b) if the parent study protocol (data on file) includes the plan for the extension

      c) if a separate published paper for the extension includes the a priori plan for the extension

      d) if a separate extension protocol (data on file) includes the plan for the extension

      Timepoints before the end of the extension study (if any) when findings will be examined, should also be pre-planned.

      K 1 Reply Last reply
      0
      • Jennifer CarrollJ Jennifer Carroll

        Great question @keoca

        “Pre-planned” means “planned at least prior to the initiation of the extension”. Post hoc, ad hoc, and exploratory analyses are not acceptable. In other words, any of the following would support “pre-planned” with regards to the extension:

        a) if the parent published study’s methodology section includes the a priori plan for the extension

        b) if the parent study protocol (data on file) includes the plan for the extension

        c) if a separate published paper for the extension includes the a priori plan for the extension

        d) if a separate extension protocol (data on file) includes the plan for the extension

        Timepoints before the end of the extension study (if any) when findings will be examined, should also be pre-planned.

        K Offline
        K Offline
        KEOCA
        wrote on last edited by
        #3

        @jennifer-carroll This is great info. It is really helping us to understand the new guidance. I have a follow-up question regarding "Timepoints before the end of the extension study..." If the extension study protocol identified that data will be analyzed before the end of the extension study, but does not identify when, is that sufficient to qualify as a pre-planned analysis?

        Jennifer CarrollJ 1 Reply Last reply
        0
        • K KEOCA

          @jennifer-carroll This is great info. It is really helping us to understand the new guidance. I have a follow-up question regarding "Timepoints before the end of the extension study..." If the extension study protocol identified that data will be analyzed before the end of the extension study, but does not identify when, is that sufficient to qualify as a pre-planned analysis?

          Jennifer CarrollJ Offline
          Jennifer CarrollJ Offline
          Jennifer Carroll
          wrote on last edited by
          #4

          Afternoon @keoca

          No that would not qualify. Specific timepoints must be clearly indicated as pre-planned.

          1 Reply Last reply
          0
          Reply
          • Reply as topic
          Log in to reply
          • Oldest to Newest
          • Newest to Oldest
          • Most Votes


          • Login

          • Don't have an account? Register

          • Login or register to search.
          • First post
            Last post
          0
          • Categories
          • Recent
          • Tags
          • Popular
          • Users
          • Groups